Comparing Semaglutide and Retatrutide (GLP3-R) — both made in America from raw material to finished vial, with 100% domestic manufacturing, packaging and shipping. This research-use reference summarizes how each is classified and what each has been studied for.
Comparing Semaglutide and Retatrutide (GLP3-R) — both made in America from raw material to finished vial, with 100% domestic manufacturing, packaging and shipping. This research-use reference summarizes how each is classified and what each has been studied for.
Semaglutide is a research peptide. Supplied as a research-grade compound for in-vitro and laboratory investigation. Our Semaglutide is made in America from raw material to finished vial, with 100% domestic manufacturing, packaging and shipping and third-party COA tested.
Retatrutide (GLP3-R) is a triple-receptor agonist. Investigated across GLP-1/GIP/glucagon pathways for energy expenditure, insulin sensitivity and metabolic regulation. Our Retatrutide (GLP3-R) is made in America from raw material to finished vial, with 100% domestic manufacturing, packaging and shipping and third-party COA tested.
Both Semaglutide and Retatrutide (GLP3-R) from PX1 are made in America from raw material to finished vial, with 100% domestic manufacturing, packaging and shipping, with ISO 17025 third-party COAs available. All material is sold for laboratory and research use only — this page does not offer medical guidance or dosing.
What is the difference between Semaglutide and Retatrutide (GLP3-R)?
Semaglutide is a research peptide; Retatrutide (GLP3-R) is a triple-receptor agonist. Each has a distinct research profile — see the sections above.
Are both made in the USA?
Yes — both are made in America from raw material to finished vial, with 100% domestic manufacturing, packaging and shipping and ship with third-party COAs available.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.